EPTMF (Epitomee Medical) ROCE %: -26.64% (As of Dec. 2025)


EPTMF Epitomee Medical Ltd EPTMF
29 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical ROCE %?

Epitomee Medical EPTMF 29 ROCE % is -26.64% as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Epitomee Medical's annualized ROCE % for the quarter that ended in Dec. 2025 was -26.64%.

Epitomee Medical  (OTCPK:EPTMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Epitomee Medical ROCE % Related Terms

Epitomee Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical ROCE % Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -20.94 -26.40 -12.32 -3.36 -22.67

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.72 -25.50 18.54 -18.86 -26.64
EPTMF
29GF Score
Epitomee Medical Ltd EPTMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical ROCE % Calculation

Epitomee Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-7.765/( ( (40.213 - 2.499) + (33.106 - 2.312) )/ 2 )
=-7.765/( (37.714+30.794)/ 2 )
=-7.765/34.254
=-22.67 %

Epitomee Medical's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-8.71/( ( (37.041 - 2.44) + (33.106 - 2.312) )/ 2 )
=-8.71/( ( 34.601 + 30.794 )/ 2 )
=-8.71/32.6975
=-26.64 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -26.64% mean?
Epitomee Medical (EPTMF) has a ROCE % of -26.64% as of Dec. 2025.
Is Epitomee Medical's ROCE % too high?
Epitomee Medical's current ROCE % is -26.64%. Overall, Epitomee Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's ROCE % compare to ABT and SYK?
Epitomee Medical's ROCE % of -26.64% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epitomee Medical's current ROCE % is -26.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current ROCE % of -26.64%. The current ROCE % is -26.64%. Epitomee Medical's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current ROCE % is -26.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
29GF Score

Get the complete analysis for EPTMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price